In the News
February 25, 2021
Rochester’s Vyriad developing oral COVID-19 vaccine
Post-Bulletin
Vyriad, a Rochester biotech firm founded by Mayo Clinic researchers, is developing an oral vaccine for the coronavirus that could be used as a booster in the months after the initial wave of vaccinations.
February 16, 2021
Company in Rochester, Minnesota Developing Oral COVID-19 Vaccine
FOX9
Vyriad, a scientific research lab based in Rochester, Minnesota, started working on a COVID-19 vaccine early last year and lab testing shows its delivery method and properties could give people immunity to the virus.
January 13, 2021
The 20 Hottest Digital Health Startups From Flyover Country, 2021
Observer
The Observer, in advance of the JP Morgan Healthcare Conference, names Imanis Life Sciences and sister company Vyriad as one of the hottest health startups from flyover country of 2021.
December 23, 2020
Heroes of the COVID Crisis: How Stephen Russel & Imanis Life Sciences Stepped Up to Make a Difference During the Pandemic
Authority Magazine
Imanis Life Sciences CEO and co-founder, Dr. Stephen Russell, talks to Authority Magazine about Heroes – what makes a hero, heroes in his own life, and heroes amid the current world climate.
December 17, 2020
If You’ve Already Had COVID-19, Do You Need the Vaccine? Here’s What Experts Say
Health
As the long-awaited COVID-19 vaccine distribution process begins in the United States, there’s plenty of deliberation around who gets the vaccine, and when.
December 9, 2020
New COVID-19 antibody test developed in Rochester
KAAL TV
While many wait for news of a COVID-19 vaccine in the United States, a Rochester company says it has created something that can help figure out if you can fight the virus off on your own.
December 9, 2020
Antibody test puts Rochester at forefront of tracking COVID-19 immunity
Post-Bulletin
How immune are you? That’s the question developers of a new COVID-19 antibody test or assay hope to answer for patients and doctors.
December 7, 2020
New test by Minnesota biotech firm can read COVID antibody levels
Star Tribune
So, what’s your titer? That question, still strange sounding, may soon become important as vaccines bring about the endgame for COVID-19.
November 19, 2020
Dueling quantitative COVID-19 neutralizing antibody tests roll out as vaccines approach completion
BioWorld
As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2.
November 9, 2020
Study suggests herd immunity to COVID-19 in New York City is low
Medical News
Researchers in the United States have estimated that the proportion of people in New York City who developed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the coronavirus disease 2019 (COVID-19) pandemic is around one in eight.
October 4, 2020
Transforming the Treatment of Cancer with Oncolytic Viruses
Decision Resources Group "Conversations in Health"
August 28, 2020
Heroes of the Pandemic
Star Tribune
Six months now into this perplexing and powerful pandemic, we’ve grown accustomed to seeing our “front line” heroes whenever we venture out and also when we don’t.
June 11, 2020
Vyriad CEO Stephen Russell discusses neutralizing antibody testing
Myeloma Crowd Radio
May 22, 2020
University of Minnesota’s Infectious Disease Center Urges Better Use of COVID-19 Testing
Star Tribune
May 13, 2020
Rochester Scientists Develop First-of-its-Kind Antibody Test to Detect Protective Immunity
Med City Beat
March 4, 2020
Dr. Stephen Russell Participates in “Creating a Cluster of Innovation in Rochester” Podcast
Finance & Commerce
November 21, 2019
Rochester Cancer-Therapy Firm to Collaborate with Drugmaker on Melanoma Treatment
Star Tribune
November 6, 2019
Rochester Biotech Firm Strikes ‘Significant’ Deal with Drug Maker
Rochester Post-Bulletin
January 17, 2019
State of the Art Cancer Therapeutics Manufacturing Headquarters Celebrates Grand Opening in Rochester Next Week
Rochester Rising
July 27, 2018
Vyriad Expands Phase 1 Trial to Test Voyager-V1 in Combination with Bevencio for Colorectal Cancer
Immuno-Oncology News
June 11, 2018
Mayo Clinic patient treated by massive measles dose still cancer-free 5 years later
Star Tribune
March 28, 2018
Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials
Twin Cities Business